quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:31:13·932d
NEWSRelease
Brainstorm Cell Therapeutics Inc. logo
Gritstone bio Inc. logo
Histogen Inc. logo
+9

12 Health Care Stocks Moving In Wednesday's Intraday Session

BCLI· Brainstorm Cell Therapeutics Inc.GRTS· Gritstone bio Inc.HSTO· Histogen Inc.IKT· Inhibikase Therapeutics Inc.INKT· MiNK Therapeutics Inc.LAB· Standard BioTools Inc.
Health CareIndustrialsTechnology
Original source

Companies

  • BCLI
    Brainstorm Cell Therapeutics Inc.
    Health Care
  • GRTS
    Gritstone bio Inc.
    Health Care
  • HSTO
    Histogen Inc.
    Health Care
  • IKT
    Inhibikase Therapeutics Inc.
    Health Care
  • INKT
    MiNK Therapeutics Inc.
    Health Care
  • LAB
    Standard BioTools Inc.
    Industrials
  • LIFW
    MSP Recovery Inc.
    Technology
  • LIPO
    Lipella Pharmaceuticals Inc.
    Health Care
  • NUVL
    Nuvalent Inc.
    Health Care
  • NUWE
    Nuwellis Inc.
    Health Care
  • PTIX
    Protagenic Therapeutics Inc.
    Health Care
  • VVOS
    Vivos Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 30NUVLUpdateWells Fargo$116.00
  • Mar 4IKTUpdateLadenburg Thalmann$4.00
  • Jan 21IKTUpdateBofA Securities$6.00
  • Dec 26IKTUpdateH.C. Wainwright$8.00
  • Dec 11IKTUpdateCantor Fitzgerald$4.00
  • Nov 24NUVLUpdateTruist-

Related

  • PR1d
    Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat
  • NEWS1d
    Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
  • SEC1d
    Vivos Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • PR3d
    Nuvalent to Present Pivotal Data from ALKOVE-1 Trial of Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC at the 2026 American Society of Clinical Oncology Annual Meeting
  • PR3d
    Nuwellis Announces Aquadex Software Update
  • PR3d
    Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
  • SEC3d
    SEC Form PRE 14A filed by Inhibikase Therapeutics Inc.
  • PR6d
    New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022